Platinum-specific detection and quantification of oxaliplatin and Pt(R,R-diaminocyclohexane)Cl2 in the blood plasma of colorectal cancer patients, J. Anal. Atom. Spectrosc., 2008, 23, 881. Quantification of cisplatin, carboplatin and oxaliplatin in spiked human plasma samples by ICP-SFMS and hydrophilic interaction liquid chromatography (HILIC) combined with ICP-MS detection, J. Anal. Atom. Spectrosc., 2009, 24, 1336. Metal-based antitumour drugs in the post-genomic era: what comes next?, Dalton Trans., 2011, 40, 9069. Modulation of drug activation profiles through carboxylate ligand modification in cytotoxic trans-platinum planar amine compounds, Dalton Trans., 2011, 40, 10983. Cationic intermediates in oxidative addition reactions of Cl2 to [PtCl(cis-1,4-DACH)], Dalton Trans., 2011, 40, 12877. Promising anticancer mono- and dinuclear ruthenium(iii) dithiocarbamato complexes: systematic solution studies, Dalton Trans., 2011, 40, 11885. Simultaneous measurement of phosphorus and platinum by Size Exclusion Chromatography coupled to Inductively Coupled Plasma Mass Spectrometry (SEC-ICPMS) using xenon as reactive collision gas for characterization of platinum drug liposomes, J. Anal. Atom. Spectrosc., 2011, 26, 1466. Stability of carboplatin and oxaliplatin in their infusion solutions is due to self-association, Dalton Trans., 2011, 40, 4821. A new platinum-complex showing easy preparation, promising anti-tumor activity, and better efficacy and distribution properties than oxaliplatin, Mol. Biosyst., 2011, 7, 3245.